Client stories
Accounts from sponsors and CRO ops leads who used our folios in steering meetings, DSMB reviews, and eligibility post-mortems.
"We handed the Week 18 folio to our Korean PI group without editing. The site bars made the Daegu lag obvious, and the footnote on lab threshold changes saved us a circular email thread."
"The DSMB chair asked for variance in days, not percentages. Ji-hoon rebuilt the ledger overnight before we boarded for Singapore. Printed tabs matched our binder dividers—small detail, large relief."
"Screen-failure analysis was thorough, though the first draft grouped consent withdrawals with lab failures in one bar—we asked to split those, and the revision arrived next morning. Worth the back-and-forth."
"Activation summary caught that three 'active' sites had not finished SIV. Our CTMS dashboard showed green icons; the Gantt strip showed reality."
Case account: Phase III NSCLC enrollment recovery
A Seoul-based sponsor opened 31 sites across Korea and Taiwan for a Phase III NSCLC study. By Week 16, cumulative randomization sat at 58% of target while internal slides still showed a single blended curve without site breakdown.
Redwood Path Analytics delivered biweekly velocity folios starting Week 18. The Busan academic site showed a screen-to-randomize ratio of 0.31 versus 0.52 study-wide; screen-failure codes pointed to prior therapy exclusions after a protocol amendment.
The sponsor redirected two CRAs to Busan for targeted source review, adjusted pre-screening checklists, and reached 94% of enrollment target four months later. The medical monitor cited folio footnotes in the DSMB minutes as the clearest enrollment evidence that cycle.
Deliverables used: Enrollment Velocity Folio (11 cycles), one Screen Failure Analysis
Share your study context
We can point to relevant sample pages under confidentiality.
Request a brief